Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes.

Nissinen, T A; Degerman, J; Räsänen, M; Poikonen, A R; Koskinen, S; Mervaala, E; Pasternack, A; Ritvos, O; Kivelä, R; Hulmi, J J

Nissinen, T A; Degerman, J; Räsänen, M; Poikonen, A R; Koskinen, S; Mervaala, E; Pasternack, A; Ritvos, O; Kivelä, R; Hulmi, J J.

Afiliación

Nissinen TA; Department of Biology of Physical Activity, Neuromuscular Research Center, University of Jyväskylä, Jyväskylä, Finland.
Degerman J; Wihuri Research Institute and Translational Cancer Biology Program, University of Helsinki, Helsinki, Finland.
Räsänen M; Wihuri Research Institute and Translational Cancer Biology Program, University of Helsinki, Helsinki, Finland.
Poikonen AR; Department of Biology of Physical Activity, Neuromuscular Research Center, University of Jyväskylä, Jyväskylä, Finland.
Koskinen S; LIKES Research Center for Sport and Health Sciences, Jyväskylä, Finland.
Mervaala E; Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Pasternack A; Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland.
Ritvos O; Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland.
Kivelä R; Department of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Hulmi JJ; Wihuri Research Institute and Translational Cancer Biology Program, University of Helsinki, Helsinki, Finland.

Sci Rep ; 6: 32695, 2016 Sep 26.

Article en En | MEDLINE | ID: mdl-27666826

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Sci Rep Año: 2016 Tipo del documento: Article País de afiliación: Finlandia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google